| 000 | 02634cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031402.0 | ||
| 008 | 160103s2014 ua dho f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.12.02.Ph.D.2014.Na.B | ||
| 100 | 0 | _aNashwa Mohammad Shams Eldin | |
| 245 | 1 | 0 |
_aBiochemical evaluation of arginase enzyme and lactoferrin protein in Egyptian diabetic patients / _cNashwa Mohammad Shams Eldin ; Supervised Sanaa Osman Abdallah , Mohamed Ali Eldesouky , Ibrahim Ali Emara |
| 246 | 1 | 5 | _aتقييم كيميائي حيوي لإنزيم الأرجيناز و بروتين الالكتوفرين في مرضى السكر المصريين |
| 260 |
_aCairo : _bNashwa Mohammad Shams Eldin , _c2014 |
||
| 300 |
_a93 P. : _bcharts , facsimiles , photographs ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
| 520 | _aThis work has been carried out to evaluate the arginase activity and lactoferrin (LF) as biochemical markers in Egyptian type 2 diabetic patients. Patients: Uncontrolled diabetic patients [G1], control diabetic patients [G2], normal healthy subjects [G3].,LF, concentration was measured using ELISA technique. Arginase and all biochemical parameters were measured by using Jenway 6105 uv/vis spectrophotometer. Finally all the results were statistically analyzed and compared with normal healthy subjects [G3]. Results: both arginase and LF were elevated in both uncontrolled diabetic patients [G1] and control diabetic patients [G2] compared to normal healthy subjects [G3]. Conclusion: The elevated serum arginase activity level and serum LF concentration originate from type 2 diabetes. As a result, both arginase activity level and LF concentration could be used to improve the clinical assessment of type 2 diabetes and might also be useful as a biological marker associated with the diabetes and a useful marker for monitoring the disease. Further, arginase enzyme activity level as well as LF concentration could be used for monitoring the diabetes therapy and detect suitable and most effective method for the treatment | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aArginase | |
| 653 | 4 | _aLactoferrin | |
| 653 | 4 | _aType 2 diabetes | |
| 700 | 0 |
_aIbrahim Ali Emara , _eSupervisor |
|
| 700 | 0 |
_aMohamed Ali Eldesouky , _eSupervisor |
|
| 700 | 0 |
_aSanaa Osman Abdallah , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aEnas _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c54243 _d54243 |
||